Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT07033533

Allopurinol and Pathogenesis of Cirrhosis

Conditions: Cirrhoses, Liver

Sex: All

Ages: 18 Years – 75 Years

Healthy volunteers: No

Phase: PHASE1, PHASE2

Enrollment: 100

Sponsor: Tanta University

Location: Tanta University Tanta

Summary

Hepatic decompensation is a common healthcare issue . This study was conducted to investigate how allopurinol can interfere with the pathological mechanisms of HD.

Eligibility Criteria

Inclusion Criteria: * age 18-75 both sex Exclusion Criteria: * active GIT bleeding

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07033533). StuddyBuddy aggregates publicly available trial information.